| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | F40IRN5981 |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma, Ovarian Epithelial; Ovarian Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Ovarian Neoplasms | Phase 2 | ClinicalTrials |
| Lung Neoplasms; Small Cell Lung Carcinoma | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 1/Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 1 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545428 |
| FDA SRS | F40IRN5981 |
| PubChem | 49779393 |
CONTENTS